French Cardiology Society

This French registry will follow 1000 patients who receive AVEIR leadless pacemakers to see how safe and effective they are in everyday use. Unlike traditional pacemakers, these devices are placed directly in the heart without wires, which may reduce complications and improve com…

This study is testing a device called LambrE that is implanted in the heart to close off a small pouch (the left atrial appendage) where blood clots often form in people with atrial fibrillation. The goal is to prevent strokes in patients who cannot take blood thinners due to ble…

This study compares two approaches for people with permanent atrial fibrillation and heart failure with preserved ejection fraction. One group gets a pacemaker plus a procedure to ablate (destroy) the heart's AV node, while the other group continues with standard heart rate medic…

This study is observing 1,000 adults with multiple or mixed heart valve disease to learn more about how the condition progresses and how it is best managed. Researchers will use heart imaging and blood tests to find markers that predict outcomes. The goal is to create better guid…

This study will use a special X-ray technique called fluoroscopy to check how often the diaphragm becomes temporarily paralyzed after pulsed field ablation, a newer treatment for atrial fibrillation. Researchers will monitor 250 adults before and after the procedure to detect any…

This study follows 500 adults with severe mitral valve disease who are not candidates for surgery. Researchers will track deaths and heart-related hospitalizations over two years to understand how these patients fare. The goal is to gather real-world data to help doctors make bet…

This study aims to see if a short, easy questionnaire can help detect sleep disorders in people visiting a heart doctor. Researchers will ask 1500 adults about their sleep and check if certain sleep problems are linked to heart disease. The goal is to make it simpler for doctors …

This study follows 314 women under 50 who had a heart attack in France. Researchers will track their health, stress, anxiety, and quality of life over several years. The goal is to learn more about long-term risks and recovery, not to test a new treatment.